Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 45,159 shares of the stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $0.93, for a total transaction of $41,997.87. Following the completion of the sale, the chief executive officer directly owned 659,644 shares in the company, valued at approximately $613,468.92. The trade was a 6.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Amit Gupta also recently made the following trade(s):
- On Tuesday, February 17th, Amit Gupta sold 52,049 shares of Cardlytics stock. The stock was sold at an average price of $0.90, for a total transaction of $46,844.10.
- On Monday, January 5th, Amit Gupta sold 5,807 shares of Cardlytics stock. The stock was sold at an average price of $1.17, for a total transaction of $6,794.19.
Cardlytics Price Performance
Shares of CDLX traded up $0.02 during mid-day trading on Wednesday, reaching $0.93. 298,906 shares of the stock traded hands, compared to its average volume of 787,275. The company has a market cap of $50.34 million, a price-to-earnings ratio of -0.44, a price-to-earnings-growth ratio of 0.15 and a beta of 1.03. Cardlytics, Inc. has a 1 year low of $0.80 and a 1 year high of $3.33. The firm has a fifty day moving average price of $1.10 and a 200 day moving average price of $1.41. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 2.87.
Analyst Upgrades and Downgrades
Institutional Trading of Cardlytics
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Lane Generational LLC raised its holdings in Cardlytics by 28.0% in the second quarter. Lane Generational LLC now owns 780,083 shares of the company’s stock worth $1,283,000 after buying an additional 170,480 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of Cardlytics during the second quarter valued at approximately $42,000. Brooktree Capital Management raised its holdings in Cardlytics by 8.3% in the 2nd quarter. Brooktree Capital Management now owns 242,249 shares of the company’s stock worth $398,000 after acquiring an additional 18,624 shares during the last quarter. Catalyst Funds Management Pty Ltd bought a new position in Cardlytics in the 2nd quarter valued at approximately $32,000. Finally, XTX Topco Ltd boosted its stake in Cardlytics by 143.5% during the 2nd quarter. XTX Topco Ltd now owns 85,971 shares of the company’s stock valued at $141,000 after purchasing an additional 50,663 shares during the last quarter. Hedge funds and other institutional investors own 68.10% of the company’s stock.
About Cardlytics
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Further Reading
- Five stocks we like better than Cardlytics
- Your Bank Account Is No Longer Safe
- What a Former CIA Agent Knows About the Coming Collapse
- Have $500? Invest in Elon’s AI Masterplan
- [How To] Invest Pre-IPO In SpaceX With $100!
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
